Pravin Desai - Sumitomo Chemical Compliance Legal
| SUMICHEM | 551.65 17.00 3.18% |
Executive
Pravin Desai is Compliance Legal of Sumitomo Chemical India
| Address | 13 & 14, Aradhana Ind. Dev. Corp., Mumbai, India, 400063 |
| Phone | 91 22 4252 2200 |
| Web | https://www.sumichem.co.in |
Sumitomo Chemical Management Efficiency
The company has return on total asset (ROA) of 0.0931 % which means that it generated a profit of $0.0931 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1846 %, meaning that it generated $0.1846 on every $100 dollars invested by stockholders. Sumitomo Chemical's management efficiency ratios could be used to measure how well Sumitomo Chemical manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Non Currrent Assets Other is expected to grow to about 570.7 M, whereas Total Assets are forecasted to decline to about 23.9 B.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Preeti Pacheriwala | Global Education Limited | N/A | |
| Yashika Malhotra | Hilton Metal Forging | N/A | |
| Senthil Kumar | TTK Healthcare Limited | 46 | |
| Pratik Jain | Sarthak Metals Limited | N/A | |
| Vivek Goyal | Fortis Healthcare Limited | N/A | |
| Mohak Malhotra | Hilton Metal Forging | N/A | |
| Aarti Sahni | Shivalik Bimetal Controls | N/A | |
| Nitin Gupta | Yatharth Hospital Trauma | N/A | |
| Shilpi Singh | Yatharth Hospital Trauma | N/A | |
| Narendra Dewangan | Sarthak Metals Limited | N/A | |
| Bipin Kumar | Fortis Healthcare Limited | N/A | |
| Satyendra Chauhan | Fortis Healthcare Limited | 48 | |
| Kabir Ghumman | Shivalik Bimetal Controls | 39 | |
| Anurag Kalra | Fortis Healthcare Limited | N/A | |
| Ajey Maharaj | Fortis Healthcare Limited | N/A | |
| R Murty | Sarthak Metals Limited | N/A | |
| Anil Vinayak | Fortis Healthcare Limited | 57 | |
| Pankaj Prabhakar | Yatharth Hospital Trauma | 48 | |
| Anirudh Singhal | Sarthak Metals Limited | 36 | |
| Kanav Anand | Shivalik Bimetal Controls | ||
| Kalyanaraman | TTK Healthcare Limited | 62 | |
Management Performance
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0931 |
Sumitomo Chemical India Leadership Team
Elected by the shareholders, the Sumitomo Chemical's board of directors comprises two types of representatives: Sumitomo Chemical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sumitomo. The board's role is to monitor Sumitomo Chemical's management team and ensure that shareholders' interests are well served. Sumitomo Chemical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sumitomo Chemical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gopalakrishnan, Member Committee | ||
| Anil Nawal, Chief Officer | ||
| Kalpesh Patel, Vice Marketing | ||
| Gaganpreet Singh, Vice Marketing | ||
| Maddika Reddy, Associate Marketing | ||
| Toshiaki Taki, Senior Operations | ||
| Deepika Trivedi, Company Officer | ||
| Anil Kakkar, Vice President | ||
| Suresh Ramachandran, Deputy Director | ||
| Chetan Shah, MD Director | ||
| Kunal Mittal, Senior Office | ||
| Sushil Marfatia, Executive Director | ||
| Pravin Desai, Compliance Legal | ||
| Pankaj Garara, Vice Marketing |
Sumitomo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sumitomo Chemical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0931 | |||
| Profit Margin | 0.16 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 262.17 B | |||
| Shares Outstanding | 499.15 M | |||
| Shares Owned By Insiders | 76.61 % | |||
| Shares Owned By Institutions | 8.58 % | |||
| Price To Book | 10.15 X | |||
| Price To Sales | 8.96 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Sumitomo Stock
Sumitomo Chemical financial ratios help investors to determine whether Sumitomo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sumitomo with respect to the benefits of owning Sumitomo Chemical security.